文献速递中医内科中药与中成药合理使用

血必净注射液对脓毒症大鼠肾损伤及皮质微循环障碍的作用

Xuebijing injection in septic rats mitigates kidney injury, reduces cortical microcirculatory disorders, and suppresses activation of local inflammation.
PubMed 文献 · J Ethnopharmacol · 2021-05-12

本研究在脓毒症大鼠模型中探讨血必净注射液作为抗生素辅助治疗对肾脏微循环障碍和炎症的影响。结果显示血必净可改善肾皮质微血管灌注和氧合,降低肾脏炎症标志物及肾损伤生物标志物水平,减轻肾组织病理损伤,但未显著降低死亡率。

要点

  • 血必净辅助抗生素可改善脓毒症大鼠肾皮质微循环灌注和氧合。
  • 血必净降低脓毒症大鼠肾脏IL-1β、IL-6、TNF-α及HMGB-1水平。
  • 血必净降低尿TIMP-2×IGFBP-7、NGAL及血肌酐,减轻肾损伤,但不影响死亡率。

核心结论

  • 在脓毒症早期大鼠模型中,血必净注射液作为抗生素辅助治疗可改善肾灌注和氧合、抑制肾脏炎症并改善肾功能,但对死亡率无影响。

研究设计与样本

  • 大鼠分为假手术组(Sham)、假手术加血必净组(Sxbj)、盲肠结扎穿孔组(CLP)及CLP加血必净组(Cxbj)。
  • 在脓毒症诱导后不同时间点评估肾皮质微血管灌注和氧合,检测肾脏炎症因子、肾损伤生物标志物及血肌酐,并进行组织学评价。

主要发现

  • 与CLP组相比,Cxbj组微血管灌注和氧合改善(p < 0.05)。
  • CLP组肾脏IL-1β、IL-6、TNF-α和HMGB-1显著升高(p < 0.05),血必净降低了这些标志物水平。
  • Cxbj组尿TIMP-2×IGFBP-7、NGAL和血肌酐水平低于CLP组(p < 0.05)。
  • CLP组Paller评分高于Cxbj组(p < 0.05)。
  • CLP组与Cxbj组死亡率无显著差异。

临床怎么用

  • 脓毒症早期可考虑在抗生素基础上辅以血必净注射液以改善肾脏微循环和炎症状态。
  • 血必净对脓毒症患者死亡率的影响尚需进一步临床研究验证。

局限性

  • 本研究为动物实验,结果不能直接外推至临床患者。
  • 研究仅观察脓毒症早期阶段,未评估长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Xuebijing injections originate from the traditional Chinese medicine (TCM) prescription XuefuZhuyu Decoction. It is composed of five Chinese herbal extracts; Carthami flos, Paeoniae radix rubra, Chuanxiong rhizoma, Salviae miltiorrhizae, and Angelicae Sinensis radix. The China Food and Drug Administration approved Xuebijing injections as a TCM preparation for the adjuvant treatment of sepsis. AIM OF THE STUDY: This study aims to determine the effects of Xuebijing injections as an adjuvant to antibiotics for the treatment of renal microcirculatory dysfunction and renal inflammation in rats with sepsis. MATERIALS AND METHODS: The rats received a sham operation (Sham), sham operation followed by Xuebijign injection (Sxbj), cecal ligation and puncture (CLP), or CLP followed by Xuebijing injection (Cxbj). Renal microvascular perfusion in the cortex and oxygenation were assessed at different times after sepsis induction. Renal levels of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and high mobility group box (HMGB)-1 were measured. Urinary TIMP-2 × IGFBP-7 and neutrophil gelatinase-associated lipocalin (NGAL) were measured as kidney biomarkers, and serum creatinine (SCr) was used to assess kidney injury. Tissue samples were stained for histologic evaluation. RESULTS: The induction of sepsis increased local inflammation and decreased renal microvascular perfusion and oxygenation. Compared with the CLP group, the Cxbj group displayed improvements in microvascular perfusion and oxygenation (p < 0.05). The CLP group had significant increases in renal inflammatory biomarkers (IL-1β, IL-6, TNF-α, and HMGB-1; p < 0.05) and Xuebijing injection reduced the levels of these markers. The levels of urinary TIMP-2 × IGFBP-7, NAGL, and SCr were lower in the Cxbj group than in the CLP group (p < 0.05), and the CLP group had a higher Paller score than the Cxbj group (p < 0.05). However, the CLP and Cxbj groups had no significant difference in mortality. CONCLUSIONS: This study into the early stages of sepsis in a rat model indicated that as an adjuvant therapy to antibiotics, Xuebijing injection improved renal perfusion and oxygenation, suppressed renal inflammation, and ameliorated kidney dysfunction. However, Xuebijing injection had no impact on mortality.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liu J, Wang Z, Lin J, et al. Xuebijing injection in septic rats mitigates kidney injury, reduces cortical microcirculatory disorders, and suppresses activation of local inflammation. J Ethnopharmacol. 2021. PMID: 33989736. doi:10.1016/j.jep.2021.114199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。